Analyzing ICU Medical (ICUI) & Its Rivals

ICU Medical (NASDAQ:ICUI – Get Free Report) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it contrast to its competitors? We will compare ICU Medical to related businesses based on the strength of its profitability, analyst recommendations, valuation, risk, earnings, institutional ownership and dividends.

Valuation & Earnings

This table compares ICU Medical and its competitors revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
ICU Medical $2.18 billion $730,000.00 76.10
ICU Medical Competitors $1.89 billion $135.83 million 5.73

ICU Medical has higher revenue, but lower earnings than its competitors. ICU Medical is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares ICU Medical and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
ICU Medical 2.76% 8.40% 4.51%
ICU Medical Competitors -270.28% -155.47% -22.38%

Volatility & Risk

ICU Medical has a beta of 0.88, meaning that its stock price is 12% less volatile than the S&P 500. Comparatively, ICU Medical’s competitors have a beta of 2.58, meaning that their average stock price is 158% more volatile than the S&P 500.

Institutional & Insider Ownership

96.1% of ICU Medical shares are held by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 2.1% of ICU Medical shares are held by insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for ICU Medical and its competitors, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ICU Medical 0 3 4 2 2.89
ICU Medical Competitors 4311 10599 18393 838 2.46

ICU Medical currently has a consensus target price of $195.20, indicating a potential upside of 7.33%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 22.52%. Given ICU Medical’s competitors higher probable upside, analysts plainly believe ICU Medical has less favorable growth aspects than its competitors.

Summary

ICU Medical beats its competitors on 8 of the 13 factors compared.

About ICU Medical

(Get Free Report)

ICU Medical is a medical technology company that develops, manufactures and markets products used in infusion therapy, vascular access and critical care. Its offerings include infusion pumps and related sets and accessories, IV solutions, needlefree connectors, and products designed to help protect healthcare workers when handling hazardous drugs. Founded in 1984, the company expanded its product portfolio through acquisitions, including the infusion systems business of Hospira in 2017 and Smiths Medical in 2022.

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.